Japan Easing Of Approval Of Previously Tested Drugs Applauded By Pfizer, GSK
This article was originally published in PharmAsia News
Executive Summary
Japan's shift to greater credit for drug trials conducted in other countries appear to be producing results, according two multinational pharmas.